Large-scale testing (Phase 3)Study completedNCT03657160
What this trial is testing
Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation
Who this might be right for
Hematopoietic Stem Cells
Millennium Pharmaceuticals, Inc. 343